TLSI TriSalus Life Sciences Inc

Price (delayed)

$3.295

Market cap

$202.37M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.32

Enterprise value

$180.3M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 25
Highlights
TriSalus Life Sciences's equity has soared by 138% from the previous quarter and by 137% YoY
TriSalus Life Sciences's quick ratio has soared by 123% from the previous quarter
TLSI's EPS is up by 28% QoQ but it is down by 18% YoY
TLSI's debt is up by 4.1% year-on-year

Key stats

What are the main financial stats of TLSI

TLSI stock price

How has the TriSalus Life Sciences stock price performed over time
Intraday
3.62%
1 week
0.76%
1 month
-25.96%
1 year
-36.14%
YTD
-52.79%
QTD
-17.63%

Financial performance

How have TriSalus Life Sciences's revenue and profit performed over time
Revenue
$44.88M
Gross profit
$38.18M
Operating income
-$28.03M
Net income
-$27.31M
Gross margin
85.1%
Net margin
-60.9%
The revenue is up by 40% year-on-year
The gross profit rose by 39% YoY
TLSI's operating margin is up by 37% YoY but it is down by 4.5% QoQ
TriSalus Life Sciences's net income has increased by 30% QoQ

Price vs fundamentals

How does TLSI's price correlate with its fundamentals

Growth

What is TriSalus Life Sciences's growth rate over time

Valuation

What is TriSalus Life Sciences stock price valuation
P/E
N/A
P/B
15.77
P/S
3.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.02
TLSI's EPS is up by 28% QoQ but it is down by 18% YoY
TriSalus Life Sciences's equity has soared by 138% from the previous quarter and by 137% YoY
The revenue is up by 40% year-on-year
TLSI's P/S is 28% below its 5-year quarterly average of 5.1 and 28% below its last 4 quarters average of 5.1

Efficiency

How efficient is TriSalus Life Sciences business performance
TLSI's ROS is up by 36% QoQ and by 33% YoY
The return on invested capital is up by 36% since the previous quarter and by 25% year-on-year
TriSalus Life Sciences's ROA has increased by 36% from the previous quarter but it has decreased by 20% YoY

Dividends

What is TLSI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TLSI.

Financial health

How did TriSalus Life Sciences financials performed over time
The company's total assets is 22% higher than its total liabilities
TLSI's current ratio has surged by 170% year-on-year and by 106% since the previous quarter
The company's total assets has surged by 148% YoY and by 101% QoQ
TLSI's debt is 169% greater than its equity
TriSalus Life Sciences's equity has soared by 138% from the previous quarter and by 137% YoY
TLSI's debt is up by 4.1% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.